Back after a week off on the theme to various notes for this week.
Katharine J. Wu says that Omicron's numerous variants and mutability have put paid to herd immunity. But, she says we can still talk about what's reasonable to hope for on U.S. societal immunity. She also notes a lot of this depends on addressing class-based privilege on medical treatment. (That's not happening.)
No comments:
Post a Comment